T R Riley1, J P Smith. 1. Department of Medicine, Penn State Geisinger Health System, Hershey 17033-0850, USA.
Abstract
OBJECTIVE: To identify preventive care measures that are appropriate for and specific to patients with chronic liver disease and to provide recommendations and information that can be shared with patients. MEASUREMENTS: A review of the literature was undertaken using MEDLINE from 1970 to present. Priority was given to randomized controlled studies, but case reports, case-control studies, and reviews were included. MAIN RESULTS: Evidence for the avoidance of alcohol and other toxic substances, immunizations, and dietary modifications for chronic liver disease is summarized. In addition, measures that are effective in the mitigation of the complications of cirrhosis are reviewed. CONCLUSIONS: Preventive care can play an important role in patients with chronic liver diseases. Based on the existing data, the preventive strategies of alcohol avoidance, hepatitis vaccination, avoidance of NSAIDs nonsteroidal anti-inflammatory drugs, iron supplementation when appropriate, and a low-fat diet are prudent in patients with chronic liver disease. Once cirrhosis develops, screening for hepatocellular cancer with alpha-fetoprotein testing and ultrasound, and screening for varices by endoscopy are justified.
OBJECTIVE: To identify preventive care measures that are appropriate for and specific to patients with chronic liver disease and to provide recommendations and information that can be shared with patients. MEASUREMENTS: A review of the literature was undertaken using MEDLINE from 1970 to present. Priority was given to randomized controlled studies, but case reports, case-control studies, and reviews were included. MAIN RESULTS: Evidence for the avoidance of alcohol and other toxic substances, immunizations, and dietary modifications for chronic liver disease is summarized. In addition, measures that are effective in the mitigation of the complications of cirrhosis are reviewed. CONCLUSIONS: Preventive care can play an important role in patients with chronic liver diseases. Based on the existing data, the preventive strategies of alcohol avoidance, hepatitis vaccination, avoidance of NSAIDs nonsteroidal anti-inflammatory drugs, iron supplementation when appropriate, and a low-fat diet are prudent in patients with chronic liver disease. Once cirrhosis develops, screening for hepatocellular cancer with alpha-fetoprotein testing and ultrasound, and screening for varices by endoscopy are justified.
Authors: A Maringhini; M Cottone; E Sciarrino; M P Marcenó; F La Seta; G Fusco; F Rinaldi; L Pagliaro Journal: Dig Dis Sci Date: 1988-01 Impact factor: 3.199
Authors: P Ginés; A Rimola; R Planas; V Vargas; F Marco; M Almela; M Forné; M L Miranda; J Llach; J M Salmerón Journal: Hepatology Date: 1990-10 Impact factor: 17.425
Authors: Sammy Saab; Peter G Konyn; Matthew R Viramontes; Melissa A Jimenez; Jonathan F Grotts; Wally Hamidzadah; Veronica P Dang; Negin L Esmailzadeh; Gina Choi; Francisco A Durazo; Mohamed M El-Kabany; Steven-Huy B Han; Myron J Tong Journal: J Clin Transl Hepatol Date: 2016-12-27